Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Meningeal Carcinomatosis 3Respiratory Tract Neoplasms 1Non Small Cell Lung Cancer NSCLC 1NSCLC 1Lung Neoplasms 1Bronchial Neoplasms 1Advanced Non-small Cell Lung Cancer 1Advanced Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

Injections 3toripalimab 1aflutinib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Lung Cancer × aflutinib × Clear all
NCT07229599 2025-11-17

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting
300 enrolled
Thoracic

Advanced Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡